He Turned Down Hundreds of Millions From Private Equity to Keep Control

Dr. Nathan Bryan is the founder and CEO of Bryan Therapeutics, a biotech building drugs that restore nitric oxide to treat heart disease, Alzheimer's, and wounds that won't heal. He spent 25 years as a professor of molecular medicine before turning his discoveries into companies. Steven Bartlett put him on The Diary of a CEO, and 84% of his website traffic now comes from people searching his own name. — CHAPTERS — 0:00 Intro 0:43 From Professor to Biotech Founder 3:00 What Nitric Oxide Does and Why You Lose It With Age 6:03 Turning a Gas Into a Pill 7:01 Why Most Beet Products Are Dead Beets 8:01 Turning Down Hundreds of Millions to Keep Control 10:03 The 5 Symptoms of Nitric Oxide Deficiency 14:21 Why AI Gets Medicine Wrong 19:42 What Keeps Him Going Through the Hardest Things 23:43 What His Father Taught Him About Perspective 25:40 Slow to Hire, Quick to Fire 32:20 Why the Healthcare System Is Failing 38:04 His Nobel-Winning Mentor and One Simple Business Rule 42:25 How He Competes Without a Big Ad Budget 47:20 Where to Find Nathan — GUEST — Dr. Nathan Bryan, Founder and CEO of Bryan Therapeutics N101: https://n101.com — LISTEN — Apple: https://podcasts.apple.com/us/podcast... Spotify: https://open.spotify.com/show/7HMfYp3... Newsletter: https://margintheory.beehiiv.com Margin Theory: https://margintheory.co — FOLLOW — LinkedIn:   / realjakeerickson   — ABOUT — Margin Theory is a media brand and financial operating system for owner-operator businesses doing $1M to $20M. Newsletter, podcast, and community plus the fractional CFO and bookkeeping services that turn the system into outcomes. #MarginTheory #BusinessPodcast #FractionalCFO

Türkei – USA Highlights | Gruppe D, FIFA WM 2026 | sportstudio
▶︎

Türkei – USA Highlights | Gruppe D, FIFA WM 2026 | sportstudio

Andrew Ross Sorkin on What 1929 Teaches Us About 2025 | The New Yorker Radio Hour
▶︎

Andrew Ross Sorkin on What 1929 Teaches Us About 2025 | The New Yorker Radio Hour

Oligarchy is worse than you think
▶︎

Oligarchy is worse than you think

JP Morgan's Michael Cembalest on the Impending Treasury Bust
▶︎

JP Morgan's Michael Cembalest on the Impending Treasury Bust

Cross-border tax planning with Sam Kyriazis and Gary Chow | Ep009
▶︎

Cross-border tax planning with Sam Kyriazis and Gary Chow | Ep009

Inside Anthropic's $100 Billion Al Compute Commitment | CFO Krishna Rao
▶︎

Inside Anthropic's $100 Billion Al Compute Commitment | CFO Krishna Rao

'An appalling way to store money': Rory Sutherland on pensions and property
▶︎

'An appalling way to store money': Rory Sutherland on pensions and property

Ben Horowitz On What Makes a Great Founder
▶︎

Ben Horowitz On What Makes a Great Founder

Inside the Mind of Anthropic CEO Dario Amodei | The Circuit | Extended Interview
▶︎

Inside the Mind of Anthropic CEO Dario Amodei | The Circuit | Extended Interview

Sheriff David Rhodes Discusses Rural County Justice and Behavioral Health Solutions
▶︎

Sheriff David Rhodes Discusses Rural County Justice and Behavioral Health Solutions

Aliko Dangote: Building Africa's industrial future from the ground up | Podcast | In Good Company
▶︎

Aliko Dangote: Building Africa's industrial future from the ground up | Podcast | In Good Company

Unlearn Negative Thoughts & Behaviors Patterns | Dr. Alok Kanojia (Healthy Gamer)
▶︎

Unlearn Negative Thoughts & Behaviors Patterns | Dr. Alok Kanojia (Healthy Gamer)

Michael O’Leary - Group CEO at Ryanair | Investment Conference 2026
▶︎

Michael O’Leary - Group CEO at Ryanair | Investment Conference 2026

David Cost, of Rainbow Apparel, on the myth of the AI‑driven job apocalypse
▶︎

David Cost, of Rainbow Apparel, on the myth of the AI‑driven job apocalypse

Inside Anthropic, the $965 Billion AI Juggernaut | The Circuit
▶︎

Inside Anthropic, the $965 Billion AI Juggernaut | The Circuit

MIT Just Revealed the AI Bubble's Fatal Flaw
▶︎

MIT Just Revealed the AI Bubble's Fatal Flaw

Gary Stevenson takes your calls | Watch in full
▶︎

Gary Stevenson takes your calls | Watch in full

AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD
▶︎

AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD

Rory Sutherland: Why Cost Reduction Isn't A Strategy
▶︎

Rory Sutherland: Why Cost Reduction Isn't A Strategy

This Is What 500 Days of Trump's Corruption Looks Like
▶︎

This Is What 500 Days of Trump's Corruption Looks Like